Sale!

FREM1 Gene Bifid Nose Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FREM1 gene plays a crucial role in embryonic development, including the formation of facial structures. Mutations in the FREM1 gene can lead to a rare congenital condition known as bifid nose, characterized by a nose divided into two parts due to a developmental anomaly. To diagnose this condition, DNA Labs UAE offers a specialized genetic test focused on identifying mutations in the FREM1 gene that are associated with a bifid nose. This test is crucial for accurate diagnosis and understanding the genetic basis of the condition, which can aid in management and counseling. The cost of the FREM1 Gene Bifid Nose Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals seeking answers about this rare genetic condition, providing them with crucial information for medical and personal decision-making.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FREM1 Gene Bifid Nose Genetic Test

At DNA Labs UAE, we offer the FREM1 Gene Bifid Nose Genetic Test to help diagnose and understand the genetic causes of bifid nose. This test can provide valuable information for genetic counseling and family planning.

Test Components

  • Test Name: FREM1 Gene Bifid Nose Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the FREM1 Gene Bifid Nose Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the FREM1 gene.

Test Details

The FREM1 gene is associated with bifid nose, a condition characterized by a split or cleft in the nose. Our Next-Generation Sequencing (NGS) genetic test utilizes high-throughput sequencing technology to analyze the FREM1 gene and identify any genetic variations or mutations that may be responsible for the development of bifid nose.

During the test, a DNA sample is obtained from an individual suspected to have bifid nose. This sample can be in the form of blood, extracted DNA, or one drop of blood on an FTA card. The DNA is then sequenced using NGS technology, and the resulting data is compared to a reference genome to identify any genetic variations or mutations in the FREM1 gene.

By identifying specific genetic variations or mutations in the FREM1 gene, our NGS genetic test can help confirm the diagnosis of bifid nose and provide important information for genetic counseling and family planning. Furthermore, it can contribute to our understanding of the underlying genetic mechanisms involved in the development of bifid nose, potentially leading to the development of targeted therapies or interventions in the future.

If you suspect that you or a family member may have bifid nose, consider undergoing the FREM1 Gene Bifid Nose Genetic Test at DNA Labs UAE. Our comprehensive and advanced testing methods can provide you with the answers you need.

Test Name FREM1 Gene Bifid nose Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FREM1 Gene Bifid nose NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FREM1 Gene Bifid nose NGS Genetic DNA Test gene FREM1
Test Details

The FREM1 gene is associated with a condition called bifid nose, which is characterized by a split or cleft in the nose. A Next-Generation Sequencing (NGS) genetic test can be used to analyze the FREM1 gene and identify any genetic variations or mutations that may be responsible for the development of bifid nose.

NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of a FREM1 gene NGS genetic test, the DNA sample of an individual suspected to have bifid nose is sequenced using NGS technology. The sequencing data is then compared to a reference genome to identify any genetic variations or mutations in the FREM1 gene.

By identifying specific genetic variations or mutations in the FREM1 gene, a NGS genetic test can help confirm the diagnosis of bifid nose and provide valuable information for genetic counseling and family planning. It can also aid in understanding the underlying genetic mechanisms involved in the development of bifid nose and potentially guide the development of targeted therapies or interventions in the future.